Inonza 1 mg Injection 1's
₹270600*
MRP ₹330000
18% off
₹280500*
MRP ₹330000
15% CB
₹49500 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Inonza 1 mg Injection 1's is an anti-cancer medicine used in the treatment of acute lymphoblastic leukemia, a blood cancer that primarily affects the blood and bone marrow. Inonza 1 mg Injection 1's is used in the treatment of patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Inonza 1 mg Injection 1's contains Inotuzumab Ozogamicin, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells.
Inonza 1 mg Injection 1's may cause certain side effects, such as skin rash, fatigue, headache, decreased platelet count, nausea, vomiting, diarrhea, abdominal pain, dizziness, myalgia, and injection site reactions. These side effects do not require medical attention and gradually resolve over time. Inonza 1 mg Injection 1's is a parenteral preparation. It will be administered by a trained oncologist. Do not self-administer.
Inonza 1 mg Injection 1's should be avoided if you are allergic to it or any other components present in it. Before taking Inonza 1 mg Injection 1's, caution should be exercised if you have/had liver/kidney disease, gastrointestinal disorders, or cardiac problems, as it may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant, planning to become pregnant or are breastfeeding before starting the treatment.
Inonza 1 mg Injection 1's contains Dasatinib, which is used in the treatment of acute lymphoblastic leukemia (ALL). It works by binding the ADC (antibody-drug conjugate) and CD22 tumor cells containing N-acetyl-gamma-calicheamicin (cytotoxic agent) and forms the ADC-CD22 complex. This complex causes the activation of N-acetyl-gamma-calicheamicin and induces DNA breakage. Thus, it helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.
Inonza 1 mg Injection 1's should be avoided if you are allergic to it or any other components present in it. Before taking, inform your doctor if you have liver/kidney disease, diabetes, cardiac problems, or increased blood pressure, as the use of Inonza 1 mg Injection 1's in these patients may cause serious side effects. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Inonza 1 mg Injection 1's is given in children above one year of age only if prescribed by the doctor. Inonza 1 mg Injection 1's may cause myelosuppression, QT prolongation, hepatotoxicity, Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome), and Increased Risk of Post-HSCT Non-Relapse Mortality in some patients. Hence, inform your doctor about your complete medical and medication history before receiving this medicine. Avoid alcohol consumption and smoking, which can lead to serious adverse effects.
Drug-Drug Interactions: Inonza 1 mg Injection 1's may interact with immunosupressants (adalimumab, infliximab, natalizumab), antiviral medicine (saquinavir, efavirenz), live vaccines, antipsychotics (haloperidol, droperidol, clozapine), antidepressants (citalopram, escitalopram), etc.
Drug-Food Interactions: Avoid alcohol consumption and smoking.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, , diabetes, and cardiac disorders before taking Inonza 1 mg Injection 1's.
Acute Lymphoblastic Leukemia (ALL): Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. There are different types of blood cancers. ALL is a type of blood cancer that primarily affects your blood and bone marrow. It mainly targets the white blood cells, which can interfere with your body’s ability to combat infections. Symptoms may include fever, weight loss, abnormal blood cell count, bruising, and loss of appetite.
Country of origin
Keep Refrigerated. Do not freeze.Prepaid payment required.
Alcohol
Caution
Avoid consuming alcohol while on treatment with Inonza 1 mg Injection 1's as it may cause severe side effects.
Pregnancy
Unsafe
Inform your doctor if you are pregnant or intend to get pregnant. You should not become pregnant while receiving Inonza 1 mg Injection 1's and for at least eight months following your last dosage. Consult your doctor about birth control techniques that will work for you. If you are a man, you and your female partner should use birth control during therapy and for at least five months following your last dosage. Call your doctor if you or your partner become pregnant while on treatment with this medicine. It may be harmful to the fetus.
Breast Feeding
Unsafe
If you are breastfeeding, notify your doctor. Your doctor may advise you not to breastfeed during your Inonza 1 mg Injection 1's treatment and for at least two months following the last dose.
Driving
Caution
Inonza 1 mg Injection 1's is administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver problems, tell your doctor before receiving this medicine. Inonza 1 mg Injection 1's is known to cause hepatotoxicity, which may be fatal. If you have any symptoms such as yellowing of your skin or the white part of your eyes (jaundice), dark or brown (tea-coloured) urine, abdominal pain, bleeding more easily than normal, or tiredness while taking Inonza 1 mg Injection 1's inform your doctor.
Kidney
Caution
If you have a pre-existing or a history of kidney diseases, inform your doctor before receiving Inonza 1 mg Injection 1's. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Unsafe
Inonza 1 mg Injection 1's is not recommended for children as the safety and effectiveness were not established.
We provide you with authentic, trustworthy and relevant information